SK283936B6 - Farmaceutický prípravok na ústne podávanie, tabletový prípravok na ústne podávanie, spôsob výroby a použitie tohto prípravku - Google Patents

Farmaceutický prípravok na ústne podávanie, tabletový prípravok na ústne podávanie, spôsob výroby a použitie tohto prípravku Download PDF

Info

Publication number
SK283936B6
SK283936B6 SK610-2001A SK6102001A SK283936B6 SK 283936 B6 SK283936 B6 SK 283936B6 SK 6102001 A SK6102001 A SK 6102001A SK 283936 B6 SK283936 B6 SK 283936B6
Authority
SK
Slovakia
Prior art keywords
moxifloxacin
pharmaceutical composition
present
tablet
lactose
Prior art date
Application number
SK610-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK6102001A3 (en
Inventor
Patrick Bosche
Hans Friedrich Mahler
Claus Weissemann
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7889824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK283936(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of SK6102001A3 publication Critical patent/SK6102001A3/sk
Publication of SK283936B6 publication Critical patent/SK283936B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK610-2001A 1998-11-10 1999-10-29 Farmaceutický prípravok na ústne podávanie, tabletový prípravok na ústne podávanie, spôsob výroby a použitie tohto prípravku SK283936B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19855758 1998-11-10
PCT/EP1999/008230 WO2000027398A1 (de) 1998-11-10 1999-10-29 Pharmazeutische zubereitung von moxifloxacin

Publications (2)

Publication Number Publication Date
SK6102001A3 SK6102001A3 (en) 2001-12-03
SK283936B6 true SK283936B6 (sk) 2004-05-04

Family

ID=7889824

Family Applications (1)

Application Number Title Priority Date Filing Date
SK610-2001A SK283936B6 (sk) 1998-11-10 1999-10-29 Farmaceutický prípravok na ústne podávanie, tabletový prípravok na ústne podávanie, spôsob výroby a použitie tohto prípravku

Country Status (41)

Country Link
US (1) US6610327B1 (cs)
EP (1) EP1128831B1 (cs)
JP (1) JP4809978B2 (cs)
KR (1) KR100650489B1 (cs)
CN (1) CN1149993C (cs)
AR (1) AR021074A1 (cs)
AT (1) ATE279193T1 (cs)
AU (1) AU745282B2 (cs)
BG (1) BG64974B1 (cs)
BR (2) BRPI9915208B8 (cs)
CA (1) CA2349161C (cs)
CO (1) CO5070571A1 (cs)
CU (1) CU23260B7 (cs)
CZ (1) CZ292069B6 (cs)
DE (1) DE59910858D1 (cs)
DK (1) DK1128831T3 (cs)
EE (1) EE04418B1 (cs)
ES (1) ES2229786T3 (cs)
HK (1) HK1042245B (cs)
HN (1) HN1999000183A (cs)
HR (1) HRP20010332B1 (cs)
HU (1) HU229065B1 (cs)
ID (1) ID29089A (cs)
IL (2) IL142642A0 (cs)
MA (1) MA26757A1 (cs)
MY (1) MY121114A (cs)
NO (1) NO319342B1 (cs)
NZ (1) NZ511554A (cs)
PE (1) PE20001304A1 (cs)
PL (1) PL194020B1 (cs)
PT (1) PT1128831E (cs)
RU (1) RU2230555C9 (cs)
SI (1) SI1128831T1 (cs)
SK (1) SK283936B6 (cs)
SV (1) SV1999000194A (cs)
TR (1) TR200101310T2 (cs)
TW (1) TW580388B (cs)
UA (1) UA72483C2 (cs)
UY (1) UY25792A1 (cs)
WO (1) WO2000027398A1 (cs)
ZA (1) ZA200103141B (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
WO2005020998A1 (en) * 2003-09-03 2005-03-10 Ranbaxy Laboratories Limited Pharmaceutical compositions of moxifloxacin and processes for their preparation
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
CN1330306C (zh) * 2004-08-11 2007-08-08 深圳市天一时科技开发有限公司 莫西沙星明胶胶囊剂及其制备方法
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
CN100363001C (zh) * 2005-09-21 2008-01-23 深圳市天一时科技开发有限公司 一种莫西沙星胶囊剂及其制备方法
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
WO2010041100A1 (en) * 2008-10-09 2010-04-15 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Using of organic solvents in wet granulation of moxifloxacin
EP2364141B2 (de) 2008-12-08 2017-08-02 ratiopharm GmbH Kompaktiertes moxifloxacin
TR200907227A2 (tr) * 2009-09-18 2011-04-21 Bi̇lgi̇ç Mahmut Çözünürlüğü yüksek stabil mikronize granüller.
CN101890169B (zh) * 2009-11-16 2013-09-11 江苏亚邦强生药业有限公司 莫西沙星口服制剂及其制备方法
WO2011086577A2 (en) * 2010-01-12 2011-07-21 Msn Laboratories Limited Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
CN102247313A (zh) * 2010-06-11 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服缓释固体制剂
CN102247314A (zh) * 2011-01-12 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服固体制剂
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
MX2011004759A (es) 2011-05-04 2012-11-21 Senosiain S A De C V Lab Nuevas formas solidas de antibioticos.
RU2466718C1 (ru) * 2011-10-14 2012-11-20 Закрытое акционерное общество "Брынцалов-А" Фармацевтический препарат моксифлоксацина
US9011892B2 (en) 2011-10-25 2015-04-21 U.S. Phytotherapy, Inc. Artemisinin with berberine compositions and methods of making
US9358261B2 (en) 2011-10-25 2016-06-07 U.S. Phytotherapy, Inc. Additional artemisinin and berberine compositions and methods of making
WO2013063271A1 (en) * 2011-10-25 2013-05-02 U.S. Phytotherapy, Inc. Artemisinin and berberine compositions and methods of making
US9675582B2 (en) 2011-10-25 2017-06-13 U.S. Phytotherapy, Inc. Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
CN109662952A (zh) * 2011-11-30 2019-04-23 富士胶片富山化学株式会社 含有1-环丙基-8-(二氟甲氧基)-7-[(1r)-1-甲基-2,3-二氢-1h-异吲哚-5-基]-4-氧代-1,4-二氢喹啉-3-羧酸的甲磺酸盐水合物的片剂
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
CN102525982A (zh) * 2012-02-21 2012-07-04 天津市汉康医药生物技术有限公司 一种稳定的盐酸莫西沙星药物组合物
CN102600093B (zh) * 2012-04-11 2013-06-05 南京优科生物医药有限公司 一种莫西沙星片剂及其制备方法
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN103768063B (zh) * 2012-10-19 2016-04-20 深圳信立泰药业股份有限公司 一种盐酸莫西沙星药物组合物及其制备方法
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
WO2015093669A1 (ko) * 2013-12-20 2015-06-25 씨제이헬스케어 주식회사 목시플록사신 수성 제형 및 이의 제조방법
RU2558932C1 (ru) * 2014-05-22 2015-08-10 Открытое Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция моксифлоксацина и способ ее приготовления

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
MX13484A (es) * 1987-10-19 1993-05-01 Pfizer Procedimiento para la obtencion de tetralinas, cromanos y compuestos relacionados, sustituidos
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
TW209865B (cs) * 1992-01-10 1993-07-21 Bayer Ag
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino

Also Published As

Publication number Publication date
DE59910858D1 (de) 2004-11-18
ZA200103141B (en) 2002-05-07
IL142642A0 (en) 2002-03-10
CO5070571A1 (es) 2001-08-28
PL348112A1 (en) 2002-05-06
HUP0104762A3 (en) 2002-10-28
AR021074A1 (es) 2002-06-12
BRPI9915208B8 (pt) 2021-07-06
HUP0104762A2 (hu) 2002-05-29
ID29089A (id) 2001-07-26
TW580388B (en) 2004-03-21
US6610327B1 (en) 2003-08-26
CN1149993C (zh) 2004-05-19
CA2349161A1 (en) 2000-05-18
MY121114A (en) 2005-12-30
UA72483C2 (en) 2005-03-15
RU2230555C9 (ru) 2006-02-27
ES2229786T3 (es) 2005-04-16
CN1325306A (zh) 2001-12-05
HRP20010332B1 (hr) 2011-01-31
WO2000027398A1 (de) 2000-05-18
TR200101310T2 (tr) 2001-10-22
NO319342B1 (no) 2005-07-18
HRP20010332A2 (en) 2002-06-30
DK1128831T3 (da) 2005-01-17
KR100650489B1 (ko) 2006-11-28
JP2002529415A (ja) 2002-09-10
BG105459A (en) 2001-12-29
EE04418B1 (et) 2005-02-15
PE20001304A1 (es) 2000-12-30
SV1999000194A (es) 2000-10-16
NO20012248L (no) 2001-06-06
NZ511554A (en) 2003-07-25
AU1267400A (en) 2000-05-29
CU23260B7 (es) 2008-01-24
EE200100259A (et) 2002-12-16
HK1042245A1 (en) 2002-08-09
PT1128831E (pt) 2005-01-31
EP1128831A1 (de) 2001-09-05
MA26757A1 (fr) 2004-12-20
HK1042245B (zh) 2005-03-11
IL142642A (en) 2006-10-05
PL194020B1 (pl) 2007-04-30
SK6102001A3 (en) 2001-12-03
ATE279193T1 (de) 2004-10-15
JP4809978B2 (ja) 2011-11-09
CA2349161C (en) 2008-01-29
CZ292069B6 (cs) 2003-07-16
AU745282B2 (en) 2002-03-21
BG64974B1 (bg) 2006-11-30
BRPI9915208B1 (pt) 2011-11-01
UY25792A1 (es) 2001-08-27
RU2230555C2 (ru) 2004-06-20
BR9915208A (pt) 2001-07-31
NO20012248D0 (no) 2001-05-07
EP1128831B1 (de) 2004-10-13
SI1128831T1 (en) 2005-04-30
KR20010089424A (ko) 2001-10-06
HU229065B1 (en) 2013-07-29
CZ20011652A3 (cs) 2001-08-15
HN1999000183A (es) 1999-11-01
BRPI9915208A (pt) 2001-07-31

Similar Documents

Publication Publication Date Title
SK283936B6 (sk) Farmaceutický prípravok na ústne podávanie, tabletový prípravok na ústne podávanie, spôsob výroby a použitie tohto prípravku
AU725622B2 (en) Pharmaceutical composition stabilized with a basic agent
CA2338256C (en) Bioenhanced formulations comprising eprosartan in oral solid dosage form
US20030175338A1 (en) Formulations of atorvastatin stabilized with alkali metal additions
SK282594B6 (sk) Spôsob prípravy tabletkového prípravku
JP2001261577A (ja) 医薬用製剤の酸化分解の抑制
CA2374117A1 (en) Novel formulations comprising lipid-regulating agents
US20080038332A1 (en) Stable pharmaceutical formulation comprising atorvastatin calcium
SK284916B6 (sk) Pevné alebo kvapalné farmaceutické prípravky obsahujúce ako účinnú látku cilansetrón, použitie kyslých prísad na stabilizáciu cilansetrónu proti racemizácii v týchto farmaceutických prípravkoch a spôsob ich prípravy
US20080221079A1 (en) Pharmaceutical composition of quetiapine fumarate
SK18582000A3 (sk) Obalené cyklofosfamidové tablety
SK2132002A3 (en) Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof
JP2004010501A (ja) 固形製剤及びその製造方法
SK114596A3 (en) Pharmaceutical combined preparation with ketoprofen

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, BERL, DE

Free format text: FORMER OWNER: BAYER HEALTHCARE AG, LEVERKUSEN, DE

Effective date: 20100614

PC4A Assignment and transfer of rights

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, MONHEIM AM R, DE

Free format text: FORMER OWNER: BAYER PHARMA AKTIENGESELLSCHAFT, BERLIN, DE

Effective date: 20130226

TC4A Change of owner's name

Owner name: BAYER PHARMA AKTIENGESELLSCHAFT, BERLIN, DE

Effective date: 20130503

MK4A Patent expired

Expiry date: 20191029